No Data
Jiawei Meikang (688246): AI-assisted diagnosis included in the medical insurance project guidelines for the first time, continuously strengthening the company's data business.
Recently, the National Medical Insurance Administration has included ai-assisted diagnosis for the first time in the project proposal guidelines, setting up 'ai-assisted' extensions in radiology examinations, ultrasound examinations, and rehabilitation projects. The company is among the earliest in the country to engage in the research and industrialization of healthcare informatization software.
Haitong Securities: AI-assisted diagnosis included in the national Medical Insurance Bureau's project guidelines AI + medical health welcomes development opportunities.
The National Healthcare Security Administration has established an "ai-assisted diagnosis" extension for radiological examinations, ultrasound examinations, and rehabilitation projects, but currently does not charge for it separately.
High Insider Ownership In Growth Companies Like Goodwill E-Health Info Plus Two More
Express News | Healthcare informatization concept stocks surged sharply, wonders information hit the 20% limit up.
Jiahe Meikang (688246) 2024 third quarter report review: Q3 performance still under pressure, continuously enhancing product competitiveness with new technologies.
Summary of this report: The performance turned into a loss year-on-year due to multiple factors, falling short of expectations, continuously exploring the cni data factor index, AI applications to strengthen product competitiveness, and opening up more growth areas. Investment highlights: Maintain shareholding. The company's performance in the first three quarters fell short of expectations, considering...
Jiawumeikang (stock code: 688246): The competitive strength of fsg medical serv a AI products continues to strengthen.
The company released the third quarter report of 2024, achieving revenue of 0.476 billion yuan in the first three quarters, a year-on-year decrease of 11.52%, achieving a net income attributable to the parent company of -0.041 billion yuan, compared to a profit of 0.018 billion yuan in the same period last year. Among them, 24
No Data
No Data